Latest News and Press Releases
Want to stay updated on the latest news?
-
TORRANCE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle cell disease treatment, announced today that it will hold an informational meeting...
-
TORRANCE, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle cell disease treatment, announced today the submission of an application to the Saudi...
-
TORRANCE, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle cell disease treatment, announced today the submission of an application to the Saudi...
-
--憩室数の減少およびより健康な組織を示す中間分析-- カリフォルニア州トーランス市, Aug. 07, 2020 (GLOBE NEWSWIRE) -- 鎌状赤血球症治療をリードするエマウスライフサイエンス社(OTCPK:...
-
캘리포니아주 토랜스, Aug. 06, 2020 (GLOBE NEWSWIRE) -- 겸상상적혈구질환 치료의 선두주자 엠마우스생명과학(“엠마우스”, OTCPK: EMMA)은 게실증 시범임상연구에서 예정된 12개월 치료기간 중, 최근 6개월 치료기간이 완료된 2명의 환자에 대한 탑라인 중간 데이터를 발표하였다. 시범임상 탑라인 중간결과가 지난 1월 29일...
-
--Interim Analysis Indicates Decreased Number of Diverticula and Healthy Tissue-- TORRANCE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle...
-
TORRANCE, Calif, July 31, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, provided today additional operational updates for the year...
-
TORRANCE Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that the European Medicines Agency (EMA)...
-
TORRANCE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the opening of its regional office in Dubai....
-
カリフォルニア州トーランス市, July 17, 2020 (GLOBE NEWSWIRE) -- 鎌状赤血球症治療をリードするエマウスライフサイエンス社(OTCQB:...